| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/18/1996 | EP0731694A1 Opioid formulations for treating pain |
| 09/18/1996 | EP0731686A1 Use of l-arginine, l-ornithine or l-citrulline and topical preparations with these substances |
| 09/18/1996 | EP0643780B1 Multiple solvent cleaning system |
| 09/18/1996 | EP0585314B1 Novel heterocyclic carboxylic acids |
| 09/18/1996 | CN1131414A Aminoindanes and related compounds useful as calcium-channel antagonists |
| 09/18/1996 | CN1131392A Nitric oxide donor composition and method for treatment of anal disorders |
| 09/18/1996 | CN1131391A Use of thiazolidinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus |
| 09/18/1996 | CN1131390A Plaster containing (E)-2-(P-fluorophenethyl)-3-fluoroallylamine for treatment of alzheimer's disease |
| 09/18/1996 | CN1131155A New tricyclic oxime ethers, processes for their preparation and pharmaceutical compositions containing them |
| 09/18/1996 | CN1131154A 8-oxy-5,8-dihydro-6H-dibenzo|a,g¨quinolizine-13-propionic acid derivant, its preparation method and medicinal use thereof |
| 09/18/1996 | CN1131150A 3-phenyl isoquinolin-1(2H)-one derivant, its preparation method and medicinal use thereof |
| 09/18/1996 | CN1131144A Glycinamide derivatives, processes for their preparation and medicines containing them |
| 09/18/1996 | CN1131041A Soft gelatin pharmaceutical dosage form |
| 09/18/1996 | CN1131035A Chinese herbal medicine composition |
| 09/18/1996 | CA2171695A1 Substituted benzothienylpiperazines their use as medicaments, and processes for their preparation |
| 09/17/1996 | US5556870 Use of leflunomide for inhibiting interleukin 1 beta |
| 09/17/1996 | US5556864 Treatment of circulatory diseases and psychosis |
| 09/17/1996 | US5556862 Pharmaceutical compositions containing isoquinoline derivatives |
| 09/17/1996 | US5556858 Cis-2-[(4-heteroaryl-1-piperazinyl)alkyl] hexahydro-1H-isoindole-1,3 (2H)-diones and related compounds and their therapeutic utility |
| 09/17/1996 | US5556856 Anitarrhythmia, analgesics |
| 09/17/1996 | US5556854 Cardiovascular disorders and/or neurogenerative disorders |
| 09/17/1996 | US5556851 Treatment of nausea or emesis from anticancer drugs or x-ray treatment |
| 09/17/1996 | US5556845 11-β substituted-19-nor steroids |
| 09/17/1996 | US5556843 Treatment of central nervous system disorders, inhibits activation of protein kinase c |
| 09/17/1996 | US5556838 Blocking n-methylaspartate receptors to prevent addiction |
| 09/17/1996 | US5556639 Lamotrigine anticonvulsant |
| 09/17/1996 | CA2004249C Arylpiperidine derivatives |
| 09/14/1996 | CA2171579A1 Piperidine derivatives, process for the preparation thereof and application thereof in therapeutics |
| 09/12/1996 | WO1996027610A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
| 09/12/1996 | WO1996027593A1 Arginine analogues having nitric oxide synthase inhibitor activity |
| 09/12/1996 | WO1996027588A1 Indole derivatives as eaa antagonists |
| 09/12/1996 | WO1996027387A1 Identification of self and non-self antigens implicated in autoimmune disease |
| 09/12/1996 | WO1996027380A1 Reduction of infarct volume using citicoline |
| 09/12/1996 | WO1996027378A2 Use of penciclovir for the treatment of human herpes-virus-8 |
| 09/12/1996 | CA2214583A1 Indole derivatives as eaa antagonists |
| 09/12/1996 | CA2213000A1 Reduction of infarct volume using citicoline |
| 09/12/1996 | CA2189738A1 Identification of self and non-self antigens implicated in autoimmune disease |
| 09/11/1996 | EP0731108A1 Method of manufacturing a therapeutic agent for the regeneration of oligodendrocytes |
| 09/11/1996 | EP0731093A1 Naphthyl pharmaceutical compounds |
| 09/11/1996 | EP0730865A1 Use of serotonin and dopamine receptor blockers for the treatment of mental disorders associated with cerebrovascular disease |
| 09/11/1996 | EP0730595A1 Imidazolinobenzodiazepines |
| 09/11/1996 | EP0730594A1 NOVEL 9-HYDROXY-PYRIDO [1,2-a]PYRIMIDIN-4-ONE ETHER DERIVATIVES |
| 09/11/1996 | EP0730589A1 Isoxazoline compounds useful as fibrinogen receptor antagonists |
| 09/11/1996 | EP0730576A1 Novel carbamate compounds and processes for preparing the same |
| 09/11/1996 | EP0730575A1 Novel carbamate compounds and processes for preparing the same |
| 09/11/1996 | EP0730461A1 The use of an ester of inositoltrisphosphate for the preparing of an analgetic medicament |
| 09/11/1996 | EP0730452A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 09/11/1996 | CN1130508A Two medicines for treating Parkinson's disease and presenile dementia and preparing process thereof |
| 09/11/1996 | CN1130505A Use of 5-acyl-1,4-dihydropyridines |
| 09/10/1996 | US5554789 Arylpropionic derivative, a process for the preparation and the use thereof as an analgesic agent |
| 09/10/1996 | US5554643 Pro-drugs for CCK antagonists |
| 09/10/1996 | US5554642 Arylalkyl(thio) amides |
| 09/10/1996 | US5554641 Nonpeptides as tachykinin antagonists |
| 09/10/1996 | US5554639 Medicaments |
| 09/10/1996 | US5554632 Central nervous system |
| 09/10/1996 | US5554621 Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives |
| 09/10/1996 | US5554620 Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof |
| 09/10/1996 | US5554614 Treatment of psychological disorders, psychoses; analgesics |
| 09/10/1996 | US5554601 Administering an estrogen compound in the absence of testosterone; treatment of alzheimer*s |
| 09/10/1996 | CA2067759C 3-phenyglutarimide derivatives as muscarinic receptor antagonists |
| 09/06/1996 | WO1996027009A1 Human amine transporter |
| 09/06/1996 | WO1996027007A1 A novel growth factor and a genetic sequence encoding same |
| 09/06/1996 | WO1996026929A1 4-aminotetrahydrobenzisoxazole or -isothiazole compounds |
| 09/06/1996 | WO1996026921A1 Novel biphenyl derivatives or salts thereof, and anti-inflammatory agents containing the same |
| 09/06/1996 | WO1996026738A1 Pharmaceutical compositions for controlled release of soluble receptors |
| 09/06/1996 | WO1996026720A1 Pharmaceutical compositions comprising monoamine oxidase b inhibitors |
| 09/06/1996 | WO1996026714A1 Process for the preparation of a solid pharmaceutical dosage form |
| 09/06/1996 | WO1996021655A3 Substituted oxazolidine calpain and/or cathepsin b inhibitors |
| 09/06/1996 | WO1996016981A3 Peptide compounds for prevention and/or treatment of no-mediated diseases |
| 09/06/1996 | CA2213127A1 4-aminotetrahydrobenzisoxazole or -isothiazole compounds |
| 09/04/1996 | EP0729960A1 Thiophene compounds and their use as intermediates in the preparation of antianxiety drugs, hypnotics, antiepileptic drugs and nuotropics |
| 09/04/1996 | EP0729958A2 Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridinyl and pyrimidinyl-piperazines |
| 09/04/1996 | EP0729758A2 Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders |
| 09/04/1996 | EP0729754A2 2-Phenyl-3-aroylbonzothiophenes for inhibiting estrogen positive tumors of the brain or CNS |
| 09/04/1996 | EP0729751A1 Controlled release formulation containing tramadol |
| 09/04/1996 | EP0729749A1 Pharmaceutical compositions containing dinoreburnamenine derivatives |
| 09/04/1996 | EP0729469A1 IMIDAZO [1,5-a]QUINOLINES FOR TREATMENT OF ANXIETY AND SLEEP DISORDERS |
| 09/04/1996 | EP0729468A1 Non-peptide tachykinin receptor antagonists |
| 09/04/1996 | EP0729459A1 Phenyl-alkyl imidazoles as h3-receptor antagonists |
| 09/04/1996 | EP0729458A1 OCTAHYDROBENZO[f]QUINOLINE-BASED RECEPTOR AGONISTS AND ANTAGONISTS |
| 09/04/1996 | EP0729455A1 Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d |
| 09/04/1996 | EP0729361A1 Method of treating neurological disorders |
| 09/04/1996 | EP0639197B1 Excitatory amino acid antagonists |
| 09/04/1996 | EP0589924B1 Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles |
| 09/04/1996 | EP0535104B1 Heterocyclic compounds and their preparation and use |
| 09/04/1996 | CN1130354A Compositions containing amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of decongestant an expectorant, an antihistamine and an antitussive |
| 09/04/1996 | CN1130352A Controlled-releasing opioid formulations for treating pain |
| 09/04/1996 | CN1130184A New Tricyclic amide compounds, processes for their preparation and the pharmaceutical compositions which contain them |
| 09/04/1996 | CN1130180A Amino (thio) ether derivative |
| 09/04/1996 | CA2170844A1 Pharmaceutical compositions containing dinoreburnamenine derivatives |
| 09/03/1996 | US5552536 DNA encoding precursor of interleukin-1 beta converting enzyme - related cysteine proteinase III (ice rel-III) |
| 09/03/1996 | US5552520 Such as somatostatin analogs or bombesin analogs |
| 09/03/1996 | US5552444 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes, 3-aminochromanes, and 3-aminothiochromanes |
| 09/03/1996 | US5552437 Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis |
| 09/03/1996 | US5552418 Trisubstituted Naphthylalkylamides |
| 09/03/1996 | US5552415 Cognition activators |
| 09/03/1996 | US5552414 Antipsychotic agents and analgesics |
| 09/03/1996 | US5552404 Compounds for neurotransmitters for animals |
| 09/03/1996 | US5552403 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 09/03/1996 | US5552396 Bis-indolemaleimide macrocyclic derivatives, |